BK261329- Erytra Eflexis
The FDA has recognized the Erytra Eflexis as a fully automated analyzer for in vitro immunohematological blood testing, utilizing DG Gel 8 cards technology for functions including blood grouping, antigen typing, and antibody screening.
Manufacturers of automated blood analyzers, clinical laboratory personnel specializing in transfusion medicine, and regulatory professionals managing diagnostic hardware submissions.
The integration of multiple complex immunohematological tests into a single automated platform suggests a move toward reducing manual intervention in blood banking. This may necessitate specific attention to automated validation protocols and software-driven diagnostic accuracy within blood laboratory quality management systems.
Regulatory and laboratory teams should ensure internal validation protocols specifically cover the full range of automated testing capabilities listed, including antibody titration and compatibility tests. Quality systems should verify that the use of DG Gel 8 cards within this automated environment remains compliant with established blood grouping and typing standards.
Erytra Eflexis is a fully automated analyzer designed to automate in vitro immunohematological testing of human blood utilizing DG Gel 8 cards technology, including Blood Grouping, Antigen Typing, Antibody Screening, Antibody Identification, Antibody Titration, Compatibility Tests, and Direct Antigl
Open in openFDA / FDA.gov